Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Lovesac

Lovesac Scores Relative Strength Rating Upgrade; Hits Key Benchmark

A Relative Strength Rating upgrade for Lovesac shows improving technical performance.

Investors Business Daily

I tried this amazing smart couch with built in surround sound and wireless charging — and it's more affordable than you'd expect

I tried this amazing smart couch with built in surround sound and wireless charging — and it's more affordable than you'd expect

Here's what to expect from the modular LoveSac StealthTech system that's currently 30% off as part of Labor Day deals.

Best bean bag beds that are supportive and comfy

Best bean bag beds that are supportive and comfy

Supreme, cloud-like comfort with a nostalgic twist

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Looking Into Lovesac's Return On Capital Employed

According to Benzinga Pro, during Q1, Lovesac (NASDAQ:LOVE) earned $1.90 million, a 94.19% increase from the preceding quarter. Lovesac's sales decreased to $129.38 million, a 34.06% change since Q4.

Why Lovesac Shares Are Plunging Today

Lovesac Co (NASDAQ:LOVE) reported first-quarter FY23 sales growth of 56% year-on-year to $129.4 million, beating the consensus of $115.02 million. Comparable sales grew 42.2%. The gross profit rose 43.5% Y/Y to $66.1 million, with the margin contracting 450 basis points to 51.1%. The operating expenses climbed 44.8% Y/Y to $63.5 million. The operating…

Dow Jones Falls As Treasury Yields Climb; Tesla Races Higher On Battery Deal

The Dow Jones Industrial Average fell Wednesday, as Treasury yields jumped. Top stocks to buy and watch include cosmetics leader Ulta Beauty.

Investors Business Daily

Lovesac: Q1 Earnings Insights

Lovesac (NASDAQ:LOVE) reported its Q1 earnings results on Wednesday, June 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Lovesac reported an EPS of $0.12.

inkl

Read news from The Economist, FT, and more,
with one subscription

Earnings Preview For Lovesac

Earnings Preview For Lovesac

Lovesac (NASDAQ:LOVE) is set to give its latest quarterly earnings report on Wednesday, 2022-06-08. Here's what investors need to know before the announcement. Analysts estimate that Lovesac will report an earnings per share (EPS) of $-0.21.

Lovesac's Stock Jumps As Q4 Earnings Smashes Estimates

Lovesac's Stock Jumps As Q4 Earnings Smashes Estimates

Lovesac Co (NASDAQ:LOVE) reported fourth-quarter FY22 sales growth of 51.3% year-on-year, to $196.2 million, beating the consensus of $174.33 million. The gross profit rose 45.9% Y/Y to $109.6 million, with the margin contracting 200 basis points to 55.9%. The operating expenses climbed 60.2% Y/Y to $85.4 million. The operating margin contracted 450 basis…

Why The Lovesac Co Shares Are Trading Higher Today

Why The Lovesac Co Shares Are Trading Higher Today

The Lovesac Co (NASDAQ: LOVE) is trading higher Tuesday after the company reported strong financial results.

Lovesac: Q4 Earnings Insights

Lovesac: Q4 Earnings Insights

Lovesac (NASDAQ:LOVE) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Earnings Preview: Lovesac

Earnings Preview: Lovesac

Lovesac (NASDAQ:LOVE) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that Lovesac will report an earnings per share (EPS) of $0.54.

Lovesac Earnings Conference Call Is Coming Up, Here's What You Need To Know

Lovesac Earnings Conference Call Is Coming Up, Here's What You Need To Know

Lovesac (NASDAQ:LOVE) will host a conference call at 08:30 AM ET on March 29, 2022, to discuss Q4 2022 earnings results. How to Attend Lovesac (LOVE) Conference Call Follow this link to access the live webcast.

Organisations

IBD MarketSmith

Western Digital

Northrop Grumman

Vertex Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

250,991 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play